"National Nurses Week"

#10674336

22 October 2023

Medics evauate a man injured by a Flashball fired by riot police. Nearly 10 000 people participated to a week end of action called 'Ramdam sur le Macadam' in the Tarn department against the decried highway A69 between Toulouse and Castres. Several corteges took place and went to different places. Police tried at several moments to blck the access to the camp at protestors even during the cortege. Several political parties, unions, ngos called to this week-end of protest. The main assocation 'La Voie est Libre' (ie 'The Way is Free'), opponents and Thomas Brail want the building of the highway to be stopped until all the justice decisions on the content to be given. All expropiations for farmers aren't cleared. Opponents at this project say that the reprofiling of the N126 will be suffisant for the 6,000 vehicles planned per day and would cost far less money. The A69 highway will cost EUR512 millions (in 2018 euros without the inflation) for 54 kilometers. More than 100 protected species and 400ha of agricultural fields will be destroyed. Saix. Tarn. France. October 21th 2023.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6558232

25 March 2021

A nurse holds a vial of AstraZeneca COVID-19 vaccine at the Military Institute of Medicine in Warsaw, Poland on March 25, 2021. AstraZeneca announced on Monday in a press release that its adenovirus vector-based vaccine demonstrated 79 percent efficacy preventing symptomatic Covid-19 and 100 percent efficacy in preventing death and hospitalization. The data released comes after a public rebuke from the National Institutes of Health concerning how AstraZeneca presented some of its older results showing higher efficacy earlier this week.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6558230

25 March 2021

A nurse fills a syringe with a vial of AstraZeneca COVID-19 vaccine at the Military Institute of Medicine in Warsaw, Poland on March 25, 2021. AstraZeneca announced on Monday in a press release that its adenovirus vector-based vaccine demonstrated 79 percent efficacy preventing symptomatic Covid-19 and 100 percent efficacy in preventing death and hospitalization. The data released comes after a public rebuke from the National Institutes of Health concerning how AstraZeneca presented some of its older results showing higher efficacy earlier this week.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6558228

25 March 2021

A nurse fills a syringe with a vial of AstraZeneca COVID-19 vaccine at the Military Institute of Medicine in Warsaw, Poland on March 25, 2021. AstraZeneca announced on Monday in a press release that its adenovirus vector-based vaccine demonstrated 79 percent efficacy preventing symptomatic Covid-19 and 100 percent efficacy in preventing death and hospitalization. The data released comes after a public rebuke from the National Institutes of Health concerning how AstraZeneca presented some of its older results showing higher efficacy earlier this week.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6558226

25 March 2021

A nurse holds a vial of AstraZeneca COVID-19 vaccine at the Military Institute of Medicine in Warsaw, Poland on March 25, 2021. AstraZeneca announced on Monday in a press release that its adenovirus vector-based vaccine demonstrated 79 percent efficacy preventing symptomatic Covid-19 and 100 percent efficacy in preventing death and hospitalization. The data released comes after a public rebuke from the National Institutes of Health concerning how AstraZeneca presented some of its older results showing higher efficacy earlier this week.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6558224

25 March 2021

A nurse fills a syringe with a vial of AstraZeneca COVID-19 vaccine at the Military Institute of Medicine in Warsaw, Poland on March 25, 2021. AstraZeneca announced on Monday in a press release that its adenovirus vector-based vaccine demonstrated 79 percent efficacy preventing symptomatic Covid-19 and 100 percent efficacy in preventing death and hospitalization. The data released comes after a public rebuke from the National Institutes of Health concerning how AstraZeneca presented some of its older results showing higher efficacy earlier this week.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6558222

25 March 2021

A nurse fills a syringe with a vial of AstraZeneca COVID-19 vaccine at the Military Institute of Medicine in Warsaw, Poland on March 25, 2021. AstraZeneca announced on Monday in a press release that its adenovirus vector-based vaccine demonstrated 79 percent efficacy preventing symptomatic Covid-19 and 100 percent efficacy in preventing death and hospitalization. The data released comes after a public rebuke from the National Institutes of Health concerning how AstraZeneca presented some of its older results showing higher efficacy earlier this week.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6558220

25 March 2021

A nurse shows a vial of AstraZeneca COVID-19 vaccine for photographers during a press event at the Military Institure of Medicine in Warsaw, Poland on March 25, 2021. AstraZeneca announced on Monday in a press release that its adenovirus vector-based vaccine demonstrated 79 percent efficacy preventing symptomatic Covid-19 and 100 percent efficacy in preventing death and hospitalization. The data released comes after a public rebuke from the National Institutes of Health concerning how AstraZeneca presented some of its older results showing higher efficacy earlier this week.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6558218

25 March 2021

A nurse grabs a vial of AstraZeneca COVID-19 vaccine at the Military Institute of Medicine in Warsaw, Poland on March 25, 2021. AstraZeneca announced on Monday in a press release that its adenovirus vector-based vaccine demonstrated 79 percent efficacy preventing symptomatic Covid-19 and 100 percent efficacy in preventing death and hospitalization. The data released comes after a public rebuke from the National Institutes of Health concerning how AstraZeneca presented some of its older results showing higher efficacy earlier this week.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6558216

25 March 2021

A vial of AstraZeneca COVID-19 vaccine is seen at the Military Institute of Medicine in Warsaw, Poland on March 25, 2021. AstraZeneca announced on Monday in a press release that its adenovirus vector-based vaccine demonstrated 79 percent efficacy preventing symptomatic Covid-19 and 100 percent efficacy in preventing death and hospitalization. The data released comes after a public rebuke from the National Institutes of Health concerning how AstraZeneca presented some of its older results showing higher efficacy earlier this week.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6558214

25 March 2021

A vial of AstraZeneca COVID-19 vaccine is seen at the Military Institute of Medicine in Warsaw, Poland on March 25, 2021. AstraZeneca announced on Monday in a press release that its adenovirus vector-based vaccine demonstrated 79 percent efficacy preventing symptomatic Covid-19 and 100 percent efficacy in preventing death and hospitalization. The data released comes after a public rebuke from the National Institutes of Health concerning how AstraZeneca presented some of its older results showing higher efficacy earlier this week.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6558212

25 March 2021

A vial of AstraZeneca COVID-19 vaccine is seen at the Military Institute of Medicine in Warsaw, Poland on March 25, 2021. AstraZeneca announced on Monday in a press release that its adenovirus vector-based vaccine demonstrated 79 percent efficacy preventing symptomatic Covid-19 and 100 percent efficacy in preventing death and hospitalization. The data released comes after a public rebuke from the National Institutes of Health concerning how AstraZeneca presented some of its older results showing higher efficacy earlier this week.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#5714972

20 May 2020

Turkish doctors and nurses lined up outside Istanbul's Taksim Education and Research Hospital on May 19, 2020 to sing the national anthem for Commemoration of Ataturk, Youth and Sports Day, a holiday in Turkey. Most of the 16 million residents of Istanbul, Turkey, stayed indoors on the final day of a four day curfew in major urban areas. Turkish cities have been using weekend lock downs to slow the spread of the coronavirus pandemic, and while the measures have been partially successful, a about 1,000 new cases are recorded daily in the country.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#5714974

20 May 2020

Turkish doctors and nurses lined up outside Istanbul's Taksim Education and Research Hospital on May 19, 2020 to sing the national anthem for Commemoration of Ataturk, Youth and Sports Day, a holiday in Turkey. Most of the 16 million residents of Istanbul, Turkey, stayed indoors on the final day of a four day curfew in major urban areas. Turkish cities have been using weekend lock downs to slow the spread of the coronavirus pandemic, and while the measures have been partially successful, a about 1,000 new cases are recorded daily in the country.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#5698684

13 May 2020

A view of poster for National Nurses Week at New York Presbyterian-Queens during the coronavirus pandemic on May 12, 2020 in Queens borough of New York City. COVID-19 has spread to most countries around the world, claiming over 270,000 lives with over 3.9 million infections reported.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#1604722

15 December 2016

Shin Bo Ra of Nurse Officer attend seated during the 3th Parliament hearing about President scandal at National Assembly in Seoul, South Korea on 14 December 2016. A friend of South Korean President Park Geun Hye at the center of a scandal that led to Park's impeachment in parliament will attend the preliminary hearing in her corruption trial next week, even through she is not required to, her lawyer said.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.